BioStem Technologies, Inc. (BSEM)
0.8181
-0.12
(-12.50%)
USD |
NASDAQ |
Nov 18, 16:00
0.8181
0.00 (0.00%)
After-Hours: 20:00
BioStem Technologies EPS Diluted (Quarterly) : -0.6368 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.6368 |
| June 30, 2026 | -0.5178 |
| March 31, 2026 | -0.5234 |
| December 31, 2025 | -0.67 |
| September 30, 2025 | 0.0334 |
| June 30, 2025 | 0.0004 |
| March 31, 2025 | 0.1488 |
| December 31, 2024 | 0.6423 |
| September 30, 2024 | 0.3228 |
| June 30, 2024 | 0.3005 |
| March 31, 2024 | 0.1686 |
| December 31, 2023 | -0.1842 |
| September 30, 2023 | -0.114 |
| June 30, 2023 | -0.2153 |
| March 31, 2023 | -0.2849 |
| December 31, 2022 | -0.3065 |
| September 30, 2022 | -0.0682 |
| June 30, 2022 | 0.0191 |
| March 31, 2022 | -0.3017 |
| December 31, 2021 | -0.0354 |
| September 30, 2021 | -0.0488 |
| June 30, 2021 | -0.0415 |
| Date | Value |
|---|---|
| March 31, 2021 | -0.0163 |
| December 31, 2020 | -0.0554 |
| September 30, 2020 | -0.0793 |
| June 30, 2020 | -0.076 |
| March 31, 2020 | -0.0454 |
| June 30, 2019 | -0.229 |
| March 31, 2019 | -0.2576 |
| December 31, 2018 | -0.4136 |
| September 30, 2018 | -0.1962 |
| June 30, 2018 | -0.1146 |
| March 31, 2018 | -0.1836 |
| December 31, 2017 | -0.0523 |
| September 30, 2017 | -0.29 |
| June 30, 2017 | -0.4925 |
| March 31, 2017 | -0.08 |
| December 31, 2016 | -0.3506 |
| September 30, 2016 | -0.70 |
| June 30, 2016 | -0.70 |
| March 31, 2016 | -0.42 |
| June 30, 2014 | -0.132 |
| March 31, 2014 | -0.176 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.2213 |
| CorMedix, Inc. | -0.1877 |
| Eloxx Pharmaceuticals, Inc. | -0.486 |
| Breakthrough Chemistry, Inc. | -0.1113 |
| Cardiac Biotech Solutions, Inc. | -0.0008 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.38M |
| Revenue (Quarterly) | 7.641M |
| Total Expenses (Quarterly) | 19.02M |
| Enterprise Value | 17.64M |
| Gross Profit Margin (Quarterly) | 46.95% |
| Profit Margin (Quarterly) | -148.9% |
| Earnings Yield | -287.0% |
| Normalized Earnings Yield | -286.99 |